Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Sales | 240,735 | 243,231 | 138,287 | 87,992 | 168,796 |
| Gross Profit | 240,735 | 243,231 | 138,287 | 87,992 | 168,796 |
| Operating Expenses | 445,737 | 421,738 | 287,323 | 181,151 | 107,605 |
| Operating Income | -205,002 | -178,507 | -149,036 | -93,159 | 61,191 |
| Interest Expense | 18,326 | 0 | 0 | 0 | 0 |
| Other Income | 16,837 | 5,798 | 8,190 | 8,608 | 6,958 |
| Pre-tax Income | -206,491 | -172,709 | -140,846 | -84,551 | 68,149 |
| Income Tax | 2,784 | 3,785 | 2 | 2 | 174 |
| Net Income Continuous | -209,275 | -176,494 | -140,848 | -84,553 | 67,975 |
| Minority Interests | -4,000 | -431 | N/A | N/A | N/A |
| Net Income | $-205,275 | $-176,063 | $-140,848 | $-84,553 | $67,975 |
| EPS Basic Total Ops | -1.92 | -1.67 | -1.36 | -0.84 | 0.72 |
| EPS Basic Continuous Ops | -1.96 | -1.67 | -1.36 | -0.84 | 0.72 |
| EPS Diluted Total Ops | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 |
| EPS Diluted Continuous Ops | -1.96 | -1.67 | -1.36 | -0.84 | 0.69 |
| EPS Diluted Before Non-Recurring Items | -1.92 | -1.67 | -1.36 | -0.84 | 0.69 |
| EBITDA(a) | $-194,526 | $-165,176 | $-140,503 | $-86,692 | $66,699 |